Pharmaceutical Executive
CMS Signals Looming Sunshine Act Audits: How to Prepare
March 1, 2024
New guidance suggests that CMS may be ramping up Sunshine Act auditing activities, potentially resulting in monetary liability for noncompliant reporting entities.
After more than a decade of relative inactivity, the Centers for Medicare & Medicaid Services(CMS) has signaled that it may soon commence audits of reporting entities under the Sunshine Act.
Published by Pharmaceutical Executive on March 1, 2024, available at https://www.pharmexec.com/view/cms-signals-looming-sunshine-act-audits-how-to-prepare.
Contacts
Capabilities
Suggested News & Insights
Sidley Medicaid Drug Rebate Program Summit Cocktail ReceptionMonday, October 5, 2026Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026For the Sixth Time, Sidley-Represented Physicians Prevail in No Surprises Act ChallengeAugust 12, 2026DOJ’s $5.15 Million FCA Settlement Reinforces Focus on Tariff and Customs ComplianceAugust 11, 2026$14.1 Million FCA Settlement Underscores Medicare Advantage Coding ScrutinyAugust 6, 2026New York Ethics Opinion Addresses Ethical Limits on Attorney Participation in Whistleblower InvestigationsJuly 30, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

